Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price rises 2.22% as stock gains today

Alkem Laboratories Share Price is trading higher today, with the stock last traded at Rs 5,202.65, up 2.22% from the previous close of Rs 5,089.50. The company’s market capitalisation stands at Rs 60,852.61 Cr, placing the move in the context of a large healthcare name rather than a small-cap swing. According to latest Univest data, the price event is confirmed, while a company-specific catalyst is not established by the market snapshot alone.

For investors tracking Alkem Laboratories Share Price Today, the immediate story is straightforward: the stock opened at Rs 5,154.95, touched a high of Rs 5,290.00 and a low of Rs 5,144.15, and showed a net gain of Rs 113.15. In Univest stock news terms, this is a clear share price rise that places Alkem among the Stocks in News from the Indian Stock Market today. The latest Univest figures also show turnover of Rs 5.07 Cr, which helps frame trading interest without overstating the move. The next things to monitor are whether the price holds above the prior close and how the stock trades relative to its healthcare peers.

Alkem Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 5,202.65
Previous Close	Rs 5,089.5
Today's Move	Rs 113.15 (+2.22%)
Open	Rs 5,154.95
High	Rs 5,290
Low	Rs 5,144.15
Turnover	Rs 5.07 crore
Market Capitalisation	Rs 60,852.61 crore
Market Cap Category	Large Cap

Alkem Laboratories Ltd. (ALKEM) rose to Rs 5,202.65 from the previous close of Rs 5,089.5, a move of Rs 113.15 or 2.22%. The stock opened at Rs 5,154.95, reached a high of Rs 5,290, recorded a low of Rs 5,144.15.

Alkem Laboratories Share Price Today reflects a firm intraday advance of Rs 113.15, or 2.22%, against the previous close of Rs 5,089.50. The stock moved between Rs 5,144.15 and Rs 5,290.00, with turnover at Rs 5.07 Cr, showing active market attention around the open and mid-morning range. The latest Univest data confirms the stock as a top gainer today in the share market today context, even though the market snapshot does not establish a company-specific trigger. For readers following Alkem Laboratories Stock News, the key point is the direction of travel: price action has been positive, and the move has been broad enough to draw Stock Market Today interest.

Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 60,852.61 crore
P/E Ratio	28.21x
P/B Ratio	4.25x
ROE	18.29%
ROCE	21.28%
EPS	Rs 180.45
Book Value Per Share	Rs 1,196.51
Dividend Yield	1.04%

Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 28.21x, P/B 4.25x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.

Alkem Laboratories Ltd. has a market capitalisation of Rs 60852.61 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.21x, P/B at 4.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 1.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.72x, median ROE of 11.69%, median ROCE of 13.24%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	28.21x
Benchmark Median P/E	32.72x
Benchmark Average P/E	49.15x
Benchmark P/E Range	3.34x to 693.7x
Company P/B Ratio	4.25x
Benchmark Median P/B	3.05x
Company ROE	18.29%
Benchmark Median ROE	11.69%
Company ROCE	21.28%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 60,852.61 crore
Benchmark Median Market Cap	Rs 704.59 crore

Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.21x, which is below the benchmark median of 32.72x, a difference of -13.78%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.69%, a difference of +56.46%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.24%, a difference of +60.73%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,41,957.5	36.54	5.11	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,47,576	84.64	14.02	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,233.01	86.76	21.08	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,670.55	24.74	4.14	19.69	21.39
Cipla Ltd.	CIPLA	1,10,272.68	32.72	3.14	11.83	16

Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.21x compared with the displayed peer median of 36.54x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 60,852.61 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Alkem Laboratories

• Alkem Laboratories Share Price is rising today with a 2.22% gain and Rs 113.15 added to the prior close.
• The stock is trading near the upper part of its intraday range, which keeps Alkem Laboratories Share Price Today in focus.
• Valuation remains below the same-industry P/E median, which makes the move relevant for fundamental analysis.
• ROE of 18.29% and ROCE of 21.28% support the company’s operating quality in healthcare stock analysis.
• Peer comparison shows a mid-to-large market cap profile with room to compare against larger pharmaceutical names.

About Alkem Laboratories

Alkem Laboratories Ltd. is a healthcare company in the Pharmaceuticals & Drugs industry. Its business profile places it in a large, competitive part of the Indian Stock Market where product breadth, execution and return ratios often matter as much as headline growth. The company is followed on NSE and BSE through Alkem Laboratories Share Price updates, and it remains a familiar name in stocks in news coverage when investors look for established pharma businesses with scale.

From a financial perspective, the latest Univest figures show a company with Rs 60,852.61 Cr market cap, EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 1.04%. Those figures help explain why Alkem Laboratories Share Price attracts both short-term market attention and longer-term fundamental analysis. In Univest research terms, the company is best understood as a large healthcare player whose current share price rise is being read through valuation, earnings and sector positioning.

Frequently Asked Questions

Why is Alkem Laboratories Share Price rising today?

Ans. Alkem Laboratories Share Price is rising today because the stock is trading Rs 113.15 higher at Rs 5,202.65, up 2.22%. The market snapshot confirms the price event, but it does not establish a company-specific catalyst.

What is Alkem Laboratories Share Price today?

Ans. Alkem Laboratories Share Price Today is Rs 5,202.65. The stock is up 2.22% from the previous close of Rs 5,089.50, which places it among the stronger names in today’s healthcare stock news.

What is Alkem Laboratories market capitalisation?

Ans. Alkem Laboratories has a market capitalisation of Rs 60,852.61 Cr. That size places the company well above the sector median and makes its share price moves important for investors following large-cap pharmaceutical stocks.

How does Alkem Laboratories compare on valuation?

Ans. Alkem Laboratories trades at a P/E ratio of 28.21 and a P/B ratio of 4.25. The P/E is below the same-industry median of 32.72, while the P/B is near the industry average of 4.37.

Are Alkem Laboratories fundamentals supportive?

Ans. Alkem Laboratories shows ROE of 18.29%, ROCE of 21.28%, EPS of Rs 180.45 and book value of Rs 1,196.51. Those figures suggest healthy profitability and a solid earnings base for stock analysis.

What does the dividend yield show for Alkem Laboratories?

Ans. Alkem Laboratories has a dividend yield of 1.04%. Dividend yield reflects the historical payout relative to the current share price, so it is useful context for income-focused investors, not a guaranteed future return.

How does Alkem Laboratories compare with healthcare peers?

Ans. Compared with peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Alkem Laboratories sits in the middle on market cap and below several peers on P/E, which can matter in peer comparison.

Where can investors track Alkem Laboratories Share Price live?

Ans. Investors can track Alkem Laboratories Share Price live on Univest along with market cap, valuation ratios, sector context and peer comparison. It is a practical way to follow Alkem Laboratories Stock News and stock performance together.

Track Alkem Laboratories Share Price on Univest

Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Alkem Laboratories Share Price on Univest for live share price updates, Alkem Laboratories Stock News, valuation ratios, market cap snapshots, sector context and peer comparison. Univest also helps readers follow Alkem Laboratories Share Price Today alongside broader market updates and stock performance checks.